Novo Nordisk
NVO
#25
Rank
โ‚น33.819 T
Marketcap
โ‚น7,624
Share price
5.18%
Change (1 day)
-23.99%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.592 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น41.89 Billion. , an increase over its 2023 earnings that were of โ‚น1.335 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น1.639 T22.75%
2023 โ‚น1.335 T57.64%
2022 โ‚น847.18 B5.35%
2021 โ‚น804.15 B12.47%
2020 โ‚น714.99 B13.07%
2019 โ‚น632.35 B-3.35%
2018 โ‚น654.27 B1.79%
2017 โ‚น642.73 B4.52%
2016 โ‚น614.93 B9.42%
2015 โ‚น562.01 B8.24%
2014 โ‚น519.23 B3.45%
2013 โ‚น501.93 B19.02%
2012 โ‚น421.72 B15.21%
2011 โ‚น366.06 B17.71%
2010 โ‚น310.97 B24.78%
2009 โ‚น249.21 B10.62%
2008 โ‚น225.28 B55.97%
2007 โ‚น144.44 B7.07%
2006 โ‚น134.90 B18.18%
2005 โ‚น114.15 B11.33%
2004 โ‚น102.53 B
2002 โ‚น63.73 B-14.39%
2001 โ‚น74.44 B-52.82%
2000 โ‚น157.77 B250%
1999 โ‚น45.07 B31.21%
1998 โ‚น34.35 B34.31%
1997 โ‚น25.57 B11.46%
1996 โ‚น22.94 B9.03%
1995 โ‚น21.04 B-3.15%
1994 โ‚น21.73 B-0.67%
1993 โ‚น21.87 B45.38%
1992 โ‚น15.04 B-13.81%
1991 โ‚น17.45 B37.12%
1990 โ‚น12.73 B-0.79%
1989 โ‚น12.83 B26.2%
1988 โ‚น10.16 B24.97%
1987 โ‚น8.13 B-0.9%
1986 โ‚น8.21 B-7.78%
1985 โ‚น8.90 B24.87%
1984 โ‚น7.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น600.93 B-63.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น878.55 B-46.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น725.23 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น641.17 B-60.89%๐Ÿ‡ซ๐Ÿ‡ท France